Xiang-Dong Li

发表

The cardioprotection of simvastatin in reperfused swine hearts relates to the inhibition of myocardial edema by modulating aquaporins via the PKA pathway.

Yuejin Yang, Y. Geng, R. Gao, 2013, International journal of cardiology.

Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway

Yuejin Yang, Y. Geng, Xiang-Dong Li, 2012, Acta Pharmacologica Sinica.

Globular Adiponectin Inhibits the Apoptosis of Mesenchymal Stem Cells Induced by Hypoxia and Serum Deprivation via the AdipoR1-Mediated Pathway

Xiang-Dong Li, K. Qi, X. Tian, 2016, Cellular Physiology and Biochemistry.

Sequential transplantation of exosomes and mesenchymal stem cells pretreated with a combination of hypoxia and Tongxinluo efficiently facilitates cardiac repair

Xiang-Dong Li, Lili Zhang, H. Qian, 2022, Stem Cell Research & Therapy.

Effect of pre‐procedural statin therapy on myocardial no‐reflow following percutaneous coronary intervention: a meta analysis

K. Dou, Yuejin Yang, D. Gu, 2013, Chinese medical journal.

China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trial

E. Peterson, Jingang Yang, Yan Liang, 2020, American Heart Journal.

No-reflow disrupts the expression and distribution of connexin 43 in a swine model.

Yuejin Yang, Xiang-Dong Li, Yu-tong Cheng, 2011, Microvascular research.

Costs and Benefits Associated With Transradial Versus Transfemoral Percutaneous Coronary Intervention in China

Jingang Yang, Wei Li, Yang Wang, 2016, Journal of the American Heart Association.

Tongxinluo attenuates oxygen-glucose-serum deprivation/restoration-induced endothelial barrier breakdown via peroxisome proliferator activated receptor-α/angiopoietin-like 4 pathway in high glucose-incubated human cardiac microvascular endothelial cells

Xian-min Meng, Xiang-Dong Li, K. Qi, 2020, Medicine.

Cardiac Microvascular Barrier Function Mediates the Protection of Tongxinluo against Myocardial Ischemia/Reperfusion Injury

Yuejin Yang, Hai-tao Zhang, Shi-jie You, 2015, PloS one.

Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome

Xiangfeng Lu, D. Gu, Lai-yuan Wang, 2015, PloS one.

Tongxinluo attenuates reperfusion injury in diabetic hearts by angiopoietin-like 4-mediated protection of endothelial barrier integrity via PPAR-α pathway

Xiang-Dong Li, K. Qi, Yuejin Yang, 2018, PloS one.

Tongxinluo-pretreated mesenchymal stem cells facilitate cardiac repair via exosomal transfer of miR-146a-5p targeting IRAK1/NF-κB p65 pathway

Jing-jing Xu, Xiang-Dong Li, Jing Xu, 2022, Stem cell research & therapy.

Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction.

Jing-jing Xu, Yuejin Yang, Xiang-Dong Li, 2021, Cardiovascular research.

Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.

Yuejin Yang, Y. Geng, Xiang-Dong Li, 2010, American journal of physiology. Heart and circulatory physiology.

PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.

Yuejin Yang, Yong-Jian Wu, Shi-jie You, 2012, Microvascular research.

Transplantation efficacy of autologous bone marrow mesenchymal stem cells combined with atorvastatin for acute myocardial infarction (TEAM-AMI): rationale and design of a randomized, double-blind, placebo-controlled, multi-center, Phase II TEAM-AMI trial.

W. Fang, Wei Li, Yang Wang, 2019, Regenerative medicine.

Elevated plasma miRNA-122, -140-3p, -720, -2861, and -3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells

Xiangfeng Lu, B. Xu, S. Qiao, 2017, PloS one.

Quantitative Proteomics Analysis of Ischemia/Reperfusion Injury-Modulated Proteins in Cardiac Microvascular Endothelial Cells and the Protective Role of Tongxinluo

Xiang-Dong Li, X. Tian, Yuejin Yang, 2017, Cellular Physiology and Biochemistry.

Tongxinluo modulates cytokine secretion by cardiac microvascular endothelial cells in ischemia/reperfusion injury.

Cong Wei, Xiang-Dong Li, K. Qi, 2016, American journal of translational research.

Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease

Chong Shen, Lin Yu, Runsheng Chen, 2012, Nature Genetics.

Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia/Reperfusion injury

T. Gillette, Joseph A. Hill, Cong Wei, 2020, Theranostics.

Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease.

Jianfeng Huang, D. Gu, Shufeng Chen, 2018, Atherosclerosis.

Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment–elevation myocardial infarction during the COVID-19 pandemic—The experience from the largest cardiovascular-specific centre in China

Jingang Yang, S. Qiao, Jin-qing Yuan, 2020, International Journal of Cardiology.

Inhibition of miR-128-3p by Tongxinluo Protects Human Cardiomyocytes from Ischemia/reperfusion Injury via Upregulation of p70s6k1/p-p70s6k1

Liping Chang, Xiang-Dong Li, X. Tian, 2017, Front. Pharmacol..

Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating SDF-1/CXCR4 axis.

Y. Geng, L. Qian, Jiandong Liu, 2019, American journal of translational research.

Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4.

Yuejin Yang, Xiang-Dong Li, Qing Li, 2015, American journal of translational research.

Induction of Autophagy by Tongxinluo Through the MEK/ERK Pathway Protects Human Cardiac Microvascular Endothelial Cells From Hypoxia/Reoxygenation Injury

Xiang-Dong Li, K. Qi, Yuejin Yang, 2014, Journal of cardiovascular pharmacology.